Back Back to portfolio

Kheiron Medical

Our mission is to help breast cancer patients live longer, better lives through earlier detection. We combine new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening. European regulatory approval is expected shortly.

Founded In



Hoxton II


London, UK

Invested In


Hoxton Partners

Rob Kniaz